# To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds

> **NCT07069920** · NA · ACTIVE_NOT_RECRUITING · sponsor: **BRPharm Co., Ltd.** · enrollment: 128 (actual)

## Conditions studied

- Nasolabial Folds

## Interventions

- **DEVICE:** BRDE33-100
- **DEVICE:** Soonsoofill

## Key facts

- **NCT ID:** NCT07069920
- **Lead sponsor:** BRPharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2025-06-25
- **Final completion:** 2026-05
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069920, "To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07069920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*